Water Island Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-155,703
Closed -$5.87M 135
2021
Q1
$5.87M Buy
+155,703
New +$3.88M 0.36% 34

Water Island Capital's FPRX Position: Q2 2021 in Review

Water Island Capital sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 155,703 shares — an estimated $5.87M sold.

Water Island Capital first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $5.87M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Water Island Capital reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Water Island Capital sold 155,703 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $5.87M.
  • Water Island Capital first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Water Island Capital's Five Prime Therapeutics, Inc. position peaked at $5.87M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Water Island Capital's 13F filing for Q2 2021, filed 12 Aug 2021.